Specimen Pilot
Get it right before it leaves the patient.
Specimen collection errors are usually caught after the fact. A mislabeled, underfilled, or mishandled sample gets rejected back at the lab, forcing a redraw and delaying care. Specimen Pilot moves that check to the bedside, guiding healthcare workers through the correct collection requirements (right patient, tube or container, volume, labeling, handling, and timing) as the draw happens, with barcode and camera verification to catch mistakes before the specimen leaves the patient.
Facilities can load their own lab rules, and Specimen Pilot tracks errors, overrides, and trends over time, helping teams see where problems keep recurring and reduce rejected specimens, redraws, delays, and the cost that comes with them.
It's built for the people already doing the draw: nursing and phlebotomy staff working at the bedside, and the lab and quality teams who otherwise only find out something went wrong once the sample is already in front of them.
The Problem
Specimen collection errors are typically discovered after the sample reaches the lab. By then, the fix is a redraw, a delay, and added cost.
The Approach
Specimen Pilot guides healthcare workers through the correct collection requirements at the bedside, with barcode and camera verification and facility-specific lab rules, so the specimen is right before it ever leaves the patient.
pooled specimen-rejection rate across a meta-analysis of 26 studies and over 16 million blood-sample requests (high heterogeneity noted by the authors - not a universal U.S. rate)
Verified· Systematic review & meta-analysis (peer-reviewed), 2024of rejections in that meta-analysis were clotted specimens; 22.87% hemolysis; 22.81% insufficient volume; 7.31% labeling errors
Verified· Systematic review & meta-analysis (peer-reviewed), 2024annual pre-analytical-error cost estimate cited by BD for an average 650-bed U.S. hospital (a published illustrative estimate, not a universal figure)
Verified· BD, 2024total U.S. hospitals, including 5,121 community hospitals and ~907,000 staffed beds
Verified· American Hospital Association, 2026total U.S. hospitals
Verified· American Hospital Association, 2026U.S. community hospitals (initial addressable segment)
Verified· American Hospital Association, 2026Labcorp AccuDraw
Specimen collection guidance
- order-specific collection instructions
- visual tube guidance
- handling instructions
- practice-management integration
Overlap: Bedside collection guidance and accuracy support
Differentiation: AccuDraw is tied to Labcorp's own lab relationship; Specimen Pilot is built to be vendor-neutral across labs and LIS platforms.
Roche S4DX / navify Sample Tracking
Specimen verification & tracking
- patient/order/container verification
- timestamps
- sample-quality information
- LIS connectivity
Overlap: Positive verification and pre-analytical quality tracking
Differentiation: Roche's tools are strongest inside a Roche lab ecosystem; Specimen Pilot targets facilities wanting quality assurance without adopting a specific lab vendor's stack.
Sunquest / Clinisys-type collection workflows
LIS-integrated collection
- positive patient ID
- barcode workflows
- labels
- collection guidance
- LIS workflow
Overlap: Barcode-driven bedside collection workflow
Differentiation: These are modules of a broader LIS; Specimen Pilot is a lightweight layer that can sit alongside whichever LIS a facility already runs.
BD
Specimen collection & quality management
- specimen collection devices
- specimen-quality management programs
Overlap: Specimen-quality focus
Differentiation: BD's strength is largely in devices and quality programs; Specimen Pilot is the software layer that guides the collection moment itself.
Why This Can Still Win
This is not an empty category: Labcorp, Roche, and LIS vendors all offer some form of collection guidance or verification today. The whitespace Specimen Pilot targets is a lightweight, vendor-neutral pre-collection quality-assurance layer that combines facility-specific rules, verification, exception prevention, and quality analytics without requiring a facility to adopt a specific lab or LIS vendor's ecosystem to get it.
Illustrative Cascadia model based on adjustable assumptions. This is not a forecast of future performance.
Downside
- MRR
- $50,000
- ARR
- $600,000
- Gross Profit
- $450,000
Base
- MRR
- $250,000
- ARR
- $3,000,000
- Gross Profit
- $2,250,000
Upside
- MRR
- $1,000,000
- ARR
- $12,000,000
- Gross Profit
- $9,000,000
Existing Cascadia Asset
- An existing, working codebase rather than a blank repository
- Product architecture and data model already designed
- UX/UI already designed and tested against a real workflow
- Product workflows already established, not hypothetical
- Market and competitive research already completed
- A defined brand and product identity
Start Internally
- Discovery and product strategy
- Architecture and data-model design
- UX/UI design
- Engineering across the full product surface
- Infrastructure and integrations
- Testing, security review, and deployment
- Iteration against real usage
- Market validation
Illustrative internal-build labor model
Using Cascadia’s illustrative internal development-team model (2 developers, 0.5 QA, 0.5 UX/interface design, 0.5 product/project management, U.S. Bureau of Labor Statistics national mean compensation benchmarks, plus a 30% Cascadia assumption for employer burden and overhead), a build over this venture’s typical timeline represents the following in modeled direct and burdened labor — before infrastructure, integrations, compliance, implementation, training, or support.
9-month build
~$450,000
12-month build
~$600,000
18-month build
~$900,000
Sources
- Systematic review & meta-analysis (peer-reviewed), “Blood specimen rejection rates: a systematic review and meta-analysis (26 studies, 16,118,499 requests)” (2024)
- BD, “Pre-analytical specimen management cost research” (2024)
- American Hospital Association, “Fast Facts on U.S. Hospitals” (2026)
Other ventures
Margin Guard
A trade intelligence and landed-cost platform that helps importers understand tariff exposure, classify products correctly, and protect margins.
Agency Bridge
An AI-powered operating layer that connects agency systems, carrier data, communications, and workflows into one workspace for insurance agencies.
Groundrise Pathways
A technology platform helping homeless and housing-insecure youth find a structured pathway toward stability, employment, education, and housing.
Interested in Specimen Pilot?
Cascadia Venture Works is open to conversations regarding strategic partnerships, licensing, pilots, investment, and acquisition opportunities where appropriate.